4//SEC Filing
FAULSTICK LUKE T 4
Accession 0001209191-18-057412
CIK 0000884624other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:34 PM ET
Size
15.2 KB
Accession
0001209191-18-057412
Insider Transaction Report
Form 4
FAULSTICK LUKE T
Director
Transactions
- Exercise/Conversion
Common Stock
2018-11-02$32.13/sh+4,300$138,159→ 10,779 total - Sale
Common Stock
2018-11-02$60.93/sh−3,600$219,330→ 7,179 total - Exercise/Conversion
Stock Option (right to buy)
2018-11-02−4,300→ 25,700 totalExercise: $32.13Exp: 2024-09-17→ Common Stock (4,300 underlying) - Sale
Common Stock
2018-11-02$61.74/sh−700$43,215→ 6,479 total - Sale
Common Stock
2018-11-02$60.93/sh−3,500$213,245→ 7,129 total - Sale
Common Stock
2018-11-02$61.72/sh−650$40,121→ 6,479 total
Footnotes (5)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
- [F5]These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018.
Documents
Issuer
Orthofix Medical Inc.
CIK 0000884624
Entity typeother
Related Parties
1- filerCIK 0001248184
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:34 PM ET
- Size
- 15.2 KB